Compounds > methylglucamine iodoxamate
Page last updated: 2024-11-13

methylglucamine iodoxamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methylglucamine iodoxamate: RN given refers to meglumine salt (2:1) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23620848
CHEMBL ID4594231
MeSH IDM0093284

Synonyms (25)

Synonym
meglumine iodoxamate
benzoic acid, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodo-, compound with 1-deoxy-1-(methylamino)-d-glucitol (1:2)
d-glucitol, 1-deoxy-1-(methylamino)-, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodobenzoate) (2:1) (salt)
3,3'-(ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodobenzoic acid) compound with 1-deoxy-1-(methylamino)-d-glucitol (1:2)
cholovue
iodoxamate meglumine [usan:ban]
iodoxamate meglumine
einecs 257-398-6
methylglucamine iodoxamate
iodoxamic acid meglumine salt
cholovue (tn)
iodoxamate meglumine (usan)
51764-33-1
D04573
cix5g6j9r1 ,
unii-cix5g6j9r1
iodoxamate meglumine [who-dd]
iodoxamate meglumine [orange book]
meglumine iodoxamate [mart.]
iodoxamate meglumine [usan]
3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol
Q27275487
CHEMBL4594231
DTXSID301027216
meglumine iodoxamate (mart.)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The incidence of eosinophilia was irrespective of dosage or type of RCM."( Eosinophilia caused by iodinated radiographic contrast media.
Kuzmanić, D; Plavsić, B; Rotkvić, I, 1983)		0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.57 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (33.33%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (55.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
metrizoate
Metrizoic Acid: A diagnostic radiopaque that usually occurs as the sodium salt.		1.9610monocarboxylic acidradioopaque medium
iodipamide
Iodipamide: A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.. adipiodone : An organoiodine compound that is 3-amino-2,4,6-triiodobenzoic acid in which one of the amino hydrogens is substituted by a 6-(3-carboxy-2,4,6-triiodoanilino)-6-oxohexanoyl group. It is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.		5.3653benzoic acids;
organoiodine compound;
secondary carboxamide		radioopaque medium
ioxaglate
Ioxaglic Acid: A low-osmolar, ionic contrast medium used in various radiographic procedures.. ioxaglic acid : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an acetyl(methyl)amino group at the 5-position.		1.9610benzenedicarboxamide;
benzoic acids;
organoiodine compound		radioopaque medium
methylglucamine metrizoate
methylglucamine metrizoate: RN given refers to parent cpd		1.9610
b 10610
iodoxamic acid: radiopaque medium used in the diagnosis of gall bladder & bile duct diseases, usually as meglumine salt; minor descriptor (81-86); on-line & INDEX MEDICUS search TRIIODOBENZOIC ACIDS (81-86)		5.5163organic molecular entity
meglumine iotroxinate
meglumine iotroxinate: Contrast media for intravenous cholecystography		5.1843
iothalamate meglumine
Iothalamate Meglumine: A radiopaque medium used for urography, angiography, venography, and myelography. It is highly viscous and binds to plasma proteins.		1.9610amidobenzoic acid
meglumine ioxithalamate
meglumine ioxithalamate: structure		1.9610
ConditionIndicatedRelationship StrengthStudiesTrials
Bile Duct Cysts
[description not available]		02.0610
Abnormalities, Digestive System
[description not available]		02.0610
Bile Duct Obstruction
[description not available]		01.9610
Liver Dysfunction
[description not available]		01.9610
Cholestasis
Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).		01.9610
Liver Diseases
Pathological processes of the LIVER.		01.9610
Eosinophilia, Tropical
[description not available]		01.9610
Eosinophilia
Abnormal increase of EOSINOPHILS in the blood, tissues or organs.		01.9610
Acute Liver Injury, Drug-Induced
[description not available]		03.3411
Chemical and Drug Induced Liver Injury
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.		03.3411
Biliary Calculi
[description not available]		01.9910
Gallstone Disease
[description not available]		01.9910
Complication, Postoperative
[description not available]		01.9910
Cholelithiasis
Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).		01.9910
Postoperative Complications
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.		01.9910
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		01.9910
Gallstones
Solid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER, resulting in the condition of CHOLELITHIASIS. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin.		01.9910